Response and correction to correspondence on "CTNBB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component"

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F21%3A10441691" target="_blank" >RIV/00216208:11140/21:10441691 - isvavai.cz</a>

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=yf.DKlJdm5" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=yf.DKlJdm5</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1038/s41379-021-00876-w" target="_blank" >10.1038/s41379-021-00876-w</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Response and correction to correspondence on "CTNBB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component"

Popis výsledku v původním jazyce

We thank the authors of &quot;CTNBB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component&quot; for their short correspondence in which they identify an error in Fig. 4 of the original paper [1, 2]. The original sequencing report was reviewed and shows a CTNNB1 c.124A&gt;G (p.Thr41Ala) mutation that was reported incorrectly in the original report. This was a typographical error in the original report. Review of the sequencing data for case 3 shows this should have indeed been a CTNNB1 c.121A&gt;G (p.Thr41Ala) mutation. This mistake was unfortunately transcribed and propagated into Table 3 and Fig. 4 and not caught during review of the Table and Figure. Table 3 and Fig. 4 have been revised (see Table 1 and Fig. 1). The body of the manuscript requires no revisions. The overall study findings remain unchanged.

Název v anglickém jazyce

Response and correction to correspondence on "CTNBB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component"

Popis výsledku anglicky

We thank the authors of &quot;CTNBB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component&quot; for their short correspondence in which they identify an error in Fig. 4 of the original paper [1, 2]. The original sequencing report was reviewed and shows a CTNNB1 c.124A&gt;G (p.Thr41Ala) mutation that was reported incorrectly in the original report. This was a typographical error in the original report. Review of the sequencing data for case 3 shows this should have indeed been a CTNNB1 c.121A&gt;G (p.Thr41Ala) mutation. This mistake was unfortunately transcribed and propagated into Table 3 and Fig. 4 and not caught during review of the Table and Figure. Table 3 and Fig. 4 have been revised (see Table 1 and Fig. 1). The body of the manuscript requires no revisions. The overall study findings remain unchanged.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30109 - Pathology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Modern Pathology

ISSN

0893-3952

e-ISSN

—

Svazek periodika

34

Číslo periodika v rámci svazku

11

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

2

Strana od-do

2089-2090

Kód UT WoS článku

000677967600001

EID výsledku v databázi Scopus

2-s2.0-85111632698